New treatment option for Psychiatric Disorder
Official title Source Monitoring Déficit in Neuropsychiatric Population
ClinicalTrials.gov ID: NCT03886584
What this study is testing
- What it's testing
- the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-monitoring will be measured thanks to internal- and reality-monitoring informatic tasks.The investigators hypothesized patients with fronto-temporal abnormalities would show more marked deficits than patients with only frontal abnormalities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80. Healthy volunteers may be eligible.
You may be able to join if
- people who gave their free and informed consent;
- Men and women;
- Aged 18 to 80;
- Having normal or corrected vision;
- Mastering the French language (read and spoken);
You likely can't join if
- Inadmissibility of the consent or refusal of the subject.
- Patients under guardianship
See the full eligibility criteria
- people who gave their free and informed consent;
- Men and women;
- Aged 18 to 80;
- Having normal or corrected vision;
- Mastering the French language (read and spoken);
- All people will not have a working memory deficit preventing the test from being passed (MMSE short version):AM patients should have a score of \<MMSE \<26; Patients with pre-dementia AD will be diagnosed according to...
- Inadmissibility of the consent or refusal of the subject.
- Patients under guardianship
The study team makes the final eligibility decision.
Where it's taking place
- Bron, Auvergne-Rhône-Alpes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, Auvergne-Rhône-Alpes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.